FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Retired Air Force Major General with Links to UFO Researcher Goes Missing – Search Underway

Legalize prostitution effort left candidate ‘shocked’ in blue state with rampant human trafficking

WATCH: Democratic Lawmaker Calls ‘Moms for Liberty’ a ‘Terrorist Group’ Then Doubles Down After Being Called Out

Old Dominion University shooter identified as Mohamed Jalloh, former National Guard member, ISIS supporter

FBI held active shooter training at Michigan synagogue weeks before attack

Manchin rips Cornyn for filibuster flip as Texas GOP runoff looms

Schumer swings at Hegseth over king crab meals for the troops, but Biden-era receipts show similar tab

Trump’s evolving stance on Iran ‘unconditional surrender’

Dems vote to keep DHS closed despite airport chaos, Iranian sleeper cell threat

BREAKING: Man Intentionally Rams Vehicle Into Michigan Synagogue and Opens Fire

Watch: Scott Jennings Calls on Internet to Fact-Check His CNN Colleague’s Insane Claim About Pete Hegseth

FBI responds to attack on Temple Israel synagogue in Michigan

Trump-backed affordable housing overhaul clears Senate, while House GOP raises red flags

Clyburn, 85, bucks Democrat generational revolt with bid for 18th term in Congress

New Bill to Ban Abortion Pill Hits Senate

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”